These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
855 related articles for article (PubMed ID: 28710745)
21. BH3 mimetic ABT-737 induces apoptosis in CD34 Rao J; Li F; Zhang RY; Zhou HH; Chen GA Asia Pac J Clin Oncol; 2017 Apr; 13(2):e144-e152. PubMed ID: 26552712 [TBL] [Abstract][Full Text] [Related]
22. Lower phosphorylation of p38 MAPK blocks the oxidative stress-induced senescence in myeloid leukemic CD34(+)CD38 (-) cells. Xiao Y; Zou P; Wang J; Song H; Zou J; Liu L J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):328-333. PubMed ID: 22684553 [TBL] [Abstract][Full Text] [Related]
23. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML. Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862 [TBL] [Abstract][Full Text] [Related]
24. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of anti-leukemic activity of the Bcl-2 homology domain-3 mimetic S1. Liu Y; Li Z; Song T; Xue Z; Zhang Z Biomed Pharmacother; 2013 Sep; 67(7):583-91. PubMed ID: 23706691 [TBL] [Abstract][Full Text] [Related]
27. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435 [TBL] [Abstract][Full Text] [Related]
28. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153 [TBL] [Abstract][Full Text] [Related]
29. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species. Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448 [TBL] [Abstract][Full Text] [Related]
30. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism. Polak A; Bialopiotrowicz E; Krzymieniewska B; Wozniak J; Stojak M; Cybulska M; Kaniuga E; Mikula M; Jablonska E; Gorniak P; Noyszewska-Kania M; Szydlowski M; Piechna K; Piwocka K; Bugajski L; Lech-Maranda E; Barankiewicz J; Kolkowska-Lesniak A; Patkowska E; Glodkowska-Mrowka E; Baran N; Juszczynski P Cell Death Dis; 2020 Nov; 11(11):956. PubMed ID: 33159047 [TBL] [Abstract][Full Text] [Related]
31. ABT-737 increases tyrosine kinase inhibitor-induced apoptosis in chronic myeloid leukemia cells through XIAP downregulation and sensitizes CD34(+) CD38(-) population to imatinib. Airiau K; Mahon FX; Josselin M; Jeanneteau M; Turcq B; Belloc F Exp Hematol; 2012 May; 40(5):367-78.e2. PubMed ID: 22240609 [TBL] [Abstract][Full Text] [Related]
32. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells. Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418 [No Abstract] [Full Text] [Related]
33. Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo. Liu F; Knight T; Su Y; Edwards H; Wang G; Wang Y; Taub JW; Lin H; Sun L; Ge Y Target Oncol; 2019 Jun; 14(3):351-364. PubMed ID: 31115744 [TBL] [Abstract][Full Text] [Related]
34. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity. Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889 [TBL] [Abstract][Full Text] [Related]
36. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595 [TBL] [Abstract][Full Text] [Related]
37. Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression. Mohammadi S; Ghaffari SH; Shaiegan M; Nikogoftar Zarif M; Nikbakht M; Alimoghaddam K; Ghavamzadeh A Int J Hematol Oncol Stem Cell Res; 2016 Jul; 10(3):120-9. PubMed ID: 27489587 [TBL] [Abstract][Full Text] [Related]
38. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444 [TBL] [Abstract][Full Text] [Related]
39. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1. Bosman MC; Schuringa JJ; Quax WJ; Vellenga E Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210 [TBL] [Abstract][Full Text] [Related]
40. BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts. Kohl TM; Hellinger C; Ahmed F; Buske C; Hiddemann W; Bohlander SK; Spiekermann K Leukemia; 2007 Aug; 21(8):1763-72. PubMed ID: 17554384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]